| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.517 | 0.034 | 0.517 | Antiobesity | 0.462 0.046 CID_15055937 | ||
| 0.524 | 0.043 | 0.524 | Analgesic | 0.448 0.066 CID_15055937 | ||
| 0.439 | 0.004 | 0.439 | Ca(v)3.3 blocker | 0.398 0.005 CID_15055937 | ||
| 0.345 | 0.006 | 0.345 | Nav1.3 sodium channel blocker | 0.249 0.014 CID_15055937 | ||
| 0.33 | 0.01 | 0.33 | Anesthetic local | 0.307 0.012 CID_15055937 | ||
| 0.396 | 0.093 | 0.401 | Cyclophilin D inhibitor | 0.401 0.09 CID_15055937 | CID_15055937 | |
| 0.324 | 0.039 | 0.324 | Potassium channel blocker | 0.189 0.1 CID_15055937 | ||
| 0.28 | 0.003 | 0.28 | Melanocortin 5 antagonist | 0.221 0.004 CID_15055937 | ||
| 0.317 | 0.044 | 0.317 | Potassium channel (Voltage-sensitive) blocker | 0.189 0.103 CID_15055937 | ||
| 0.312 | 0.051 | 0.312 | Cardiotonic | 0.262 0.075 CID_15055937 | ||
| 0.267 | 0.007 | 0.267 | Nav1.5 sodium channel blocker | 0.178 0.017 CID_15055937 | ||
| 0.272 | 0.014 | 0.272 | Sodium channel blocker | 0.161 0.051 CID_15055937 | ||
| 0.285 | 0.041 | 0.293 | Tyrosine 3 hydroxylase inhibitor | 0.293 0.036 CID_15055937 | CID_15055937 | |
| 0.254 | 0.014 | 0.254 | Sodium channel (voltage-gated) blocker | 0.156 0.05 CID_15055937 | ||
| 0.216 | 0.009 | 0.216 | CXC chemokine 4 receptor antagonist | 0.183 0.012 CID_15055937 | ||
| 0.204 | 0.007 | 0.204 | Nav1.8 sodium channel blocker | 0.149 0.014 CID_15055937 | ||
| 0.196 | 0.004 | 0.196 | Glycine transporter inhibitor | 0.096 0.012 CID_15055937 | ||
| 0.273 | 0.089 | 0.273 | Nootropic | 0.201 0.157 CID_15055937 | ||
| 0.313 | 0.146 | 0.361 | Calcium channel L-type activator | 0.361 0.109 CID_15055937 | CID_15055937 | |
| 0.187 | 0.035 | 0.187 | Calcium channel blocker | 0.132 0.075 CID_15055937 | ||
| 0.179 | 0.029 | 0.179 | Nav1.6 sodium channel blocker | 0.144 0.061 CID_15055937 | ||
| 0.215 | 0.066 | 0.215 | Nitric-oxide synthase stimulant | 0.206 0.079 CID_15055937 | ||
| 0.175 | 0.028 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | 0.164 0.04 CID_15055937 | ||
| 0.269 | 0.125 | 0.269 | Calcium channel activator | 0.264 0.131 CID_15055937 | ||
| 0.151 | 0.008 | 0.151 | Melanocortin antagonist | 0.098 0.012 CID_15055937 | ||
| 0.184 | 0.041 | 0.184 | Nav1.2 sodium channel blocker | 0.136 0.067 CID_15055937 | ||
| 0.183 | 0.041 | 0.183 | Hemostatic | 0.17 0.049 CID_15055937 | ||
| 0.156 | 0.016 | 0.156 | ABCA1 expression enhancer | 0.132 0.023 CID_15055937 | ||
| 0.137 | 0.007 | 0.137 | Ca(v)3.1 blocker | 0.127 0.009 CID_15055937 | ||
| 0.149 | 0.02 | 0.149 | Acetylcholine nicotinic antagonist | 0.102 0.038 CID_15055937 | ||
| 0.141 | 0.013 | 0.141 | Neuronal nicotinic receptor antagonist | 0.096 0.026 CID_15055937 | ||
| 0.14 | 0.012 | 0.14 | CXC chemokine receptor antagonist | 0.123 0.016 CID_15055937 | ||
| 0.21 | 0.084 | 0.21 | HERG channel blocker | |||
| 0.156 | 0.033 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.15 0.041 CID_15055937 | ||
| 0.164 | 0.045 | 0.164 | Cholinergic antagonist | 0.157 0.049 CID_15055937 | ||
| 0.198 | 0.081 | 0.198 | Psychostimulant | 0.148 0.118 CID_15055937 | ||
| 0.161 | 0.044 | 0.161 | Acetylcholine antagonist | 0.153 0.048 CID_15055937 | ||
| 0.146 | 0.036 | 0.146 | Calcium channel (voltage-sensitive) blocker | 0.107 0.075 CID_15055937 | ||
| 0.113 | 0.007 | 0.113 | Ca(v)3.2 blocker | 0.104 0.008 CID_15055937 | ||
| 0.098 | 0.009 | 0.098 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.015 CID_15055937 | ||
| 0.093 | 0.008 | 0.093 | Growth hormone secretagogue receptor agonist | 0.057 0.017 CID_15055937 | ||
| 0.094 | 0.013 | 0.094 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 CID_15055937 | ||
| 0.089 | 0.014 | 0.089 | Nicotinic receptor alpha7 subunit antagonist | 0.058 0.031 CID_15055937 | ||
| 0.094 | 0.022 | 0.094 | Secretase beta inhibitor | 0.083 0.033 CID_15055937 | ||
| 0.084 | 0.014 | 0.096 | Sphingosine kinase inhibitor | 0.096 0.009 CID_15055937 | CID_15055937 | |
| 0.086 | 0.022 | 0.086 | Orexin receptor antagonist | |||
| 0.084 | 0.021 | 0.084 | Calcium channel T-type blocker | 0.054 0.048 CID_15055937 | ||
| 0.096 | 0.034 | 0.096 | Dopamine D2 antagonist | 0.061 0.049 CID_15055937 | ||
| 0.11 | 0.05 | 0.11 | Antiadrenergic | 0.087 0.065 CID_15055937 | ||
| 0.107 | 0.047 | 0.107 | Glutamate (mGluR7) agonist | |||
| 0.097 | 0.038 | 0.097 | Histamine H2 receptor antagonist | |||
| 0.108 | 0.049 | 0.108 | Adrenaline antagonist | 0.085 0.064 CID_15055937 | ||
| 0.073 | 0.016 | 0.073 | Potassium channel (Inward rectifier) blocker | |||
| 0.059 | 0.003 | 0.059 | 5 Hydroxytryptamine 4 agonist | 0.033 0.005 CID_15055937 | ||
| 0.127 | 0.071 | 0.127 | Antibacterial (Helicobacter pylori) | 0.118 0.083 CID_15055937 | ||
| 0.108 | 0.052 | 0.108 | Alpha adrenoreceptor antagonist | |||
| 0.121 | 0.066 | 0.125 | Acetylcholine muscarinic antagonist | 0.125 0.062 CID_15055937 | CID_15055937 | |
| 0.06 | 0.007 | 0.06 | Glucose-6-phosphate dehydrogenase inhibitor | 0.057 0.008 CID_15055937 | ||
| 0.165 | 0.112 | 0.165 | Anticonvulsant | |||
| 0.068 | 0.017 | 0.068 | Prolyl endopeptidase inhibitor | 0.052 0.034 CID_15055937 | ||
| 0.081 | 0.033 | 0.081 | Nav1.7 sodium channel blocker | |||
| 0.106 | 0.059 | 0.106 | Nav1.1 sodium channel blocker | 0.091 0.078 CID_15055937 | ||
| 0.08 | 0.034 | 0.08 | Orexin receptor 1 antagonist | |||
| 0.056 | 0.011 | 0.064 | Sphingosine kinase 1 inhibitor | 0.064 0.008 CID_15055937 | CID_15055937 | |
| 0.104 | 0.059 | 0.104 | Chemokine receptor antagonist | |||
| 0.088 | 0.043 | 0.088 | Dopamine antagonist | 0.065 0.059 CID_15055937 | ||
| 0.083 | 0.039 | 0.083 | Epoxide hydrolase inhibitor | |||
| 0.054 | 0.011 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.051 0.013 CID_15055937 | ||
| 0.134 | 0.095 | 0.134 | Anticoagulant | 0.127 0.103 CID_15055937 | ||
| 0.082 | 0.042 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.062 CID_15055937 | ||
| 0.053 | 0.014 | 0.053 | Somatostatin 4 agonist | 0.043 0.019 CID_15055937 | ||
| 0.06 | 0.022 | 0.06 | Antiviral (Hepatitis D) | 0.051 0.034 CID_15055937 | ||
| 0.071 | 0.037 | 0.078 | Beta adrenoreceptor antagonist | 0.078 0.029 CID_15055937 | CID_15055937 | |
| 0.196 | 0.163 | 0.229 | Insulysin inhibitor | 0.229 0.118 CID_15055937 | CID_15055937 | |
| 0.076 | 0.044 | 0.076 | 5 Hydroxytryptamine agonist | |||
| 0.048 | 0.016 | 0.048 | Glycine transporter 1 inhibitor | |||
| 0.06 | 0.029 | 0.06 | Epithelial sodium channel blocker | 0.054 0.04 CID_15055937 | ||
| 0.035 | 0.005 | 0.035 | Somatostatin 2 agonist | 0.029 0.005 CID_15055937 | ||
| 0.041 | 0.013 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.029 CID_15055937 | ||
| 0.042 | 0.016 | 0.042 | Somatostatin agonist | 0.035 0.019 CID_15055937 | ||
| 0.168 | 0.144 | 0.168 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 2A agonist | |||
| 0.112 | 0.089 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.057 | 0.035 | 0.069 | Glucosylceramidase inhibitor | 0.069 0.022 CID_15055937 | CID_15055937 | |
| 0.126 | 0.104 | 0.143 | Thrombolytic | 0.143 0.087 CID_15055937 | CID_15055937 | |
| 0.166 | 0.149 | 0.192 | Spasmolytic | 0.192 0.126 CID_15055937 | CID_15055937 | |
| 0.156 | 0.139 | 0.223 | Antiamyloidogenic | 0.223 0.085 CID_15055937 | CID_15055937 | |
| 0.072 | 0.055 | 0.072 | Rho-associated kinase I inhibitor | |||
| 0.037 | 0.021 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 CID_15055937 | CID_15055937 | |
| 0.052 | 0.038 | 0.052 | Dipeptidyl peptidase inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | 0.025 0.015 CID_15055937 | ||
| 0.048 | 0.036 | 0.048 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.032 | 0.019 | 0.032 | Potassium channel subfamily K member 3 blocker | |||
| 0.102 | 0.091 | 0.102 | Calcium channel N-type blocker | |||
| 0.079 | 0.068 | 0.079 | Alpha 2 adrenoreceptor antagonist | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.043 | 0.033 | 0.043 | Dihydroorotase inhibitor | 0.041 0.036 CID_15055937 | ||
| 0.061 | 0.052 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 CID_15055937 | CID_15055937 | |
| 0.019 | 0.011 | 0.019 | Complement factor D inhibitor | |||
| 0.152 | 0.146 | 0.152 | MAP kinase kinase 5 inhibitor | |||
| 0.027 | 0.021 | 0.029 | Motilin receptor antagonist | 0.029 0.017 CID_15055937 | CID_15055937 | |
| 0.09 | 0.085 | 0.09 | Alpha 2b adrenoreceptor antagonist | |||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.055 | 0.051 | 0.055 | TRPA1 antagonist | |||
| 0.051 | 0.047 | 0.051 | Potassium channel Kv1.5 blocker | |||
| 0.196 | 0.192 | 0.196 | Calpain 2 inhibitor | |||
| 0.049 | 0.046 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.026 CID_15055937 | CID_15055937 | |
| 0.05 | 0.047 | 0.053 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 CID_15055937 | CID_15055937 | |
| 0.026 | 0.023 | 0.026 | Melatonin antagonist | |||
| 0.018 | 0.016 | 0.018 | Somatostatin 3 agonist | |||
| 0.163 | 0.166 | 0.227 | Superoxide dismutase inhibitor | 0.227 0.092 CID_15055937 | CID_15055937 | |
| 0.05 | 0.054 | 0.062 | Acetylcholine M3 receptor antagonist | 0.062 0.039 CID_15055937 | CID_15055937 | |
| 0.043 | 0.047 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 CID_15055937 | CID_15055937 | |
| 0.071 | 0.076 | 0.077 | I kappa B kinase inhibitor | 0.077 0.065 CID_15055937 | CID_15055937 | |
| 0.112 | 0.121 | 0.118 | Acetylcholine M1 receptor antagonist | 0.118 0.112 CID_15055937 | CID_15055937 | |
| 0.036 | 0.048 | 0.047 | Mannosidase inhibitor | 0.047 0.029 CID_15055937 | CID_15055937 | |
| 0.105 | 0.133 | 0.132 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.057 CID_15055937 | CID_15055937 | |
| 0.114 | 0.148 | 0.142 | Melanin inhibitor | 0.142 0.094 CID_15055937 | CID_15055937 | |
| 0.103 | 0.137 | 0.114 | Vanilloid 1 agonist | 0.114 0.102 CID_15055937 | CID_15055937 | |
| 0.036 | 0.09 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.039 CID_15055937 | CID_15055937 | |
| 0.121 | 0.179 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.129 CID_15055937 | CID_15055937 | |
| 0.121 | 0.187 | 0.169 | Immunostimulant | 0.169 0.14 CID_15055937 | CID_15055937 | |
| 0.046 | 0.112 | 0.062 | Potassium channel large-conductance Ca-activated activator | 0.062 0.057 CID_15055937 | CID_15055937 | |
| 0.08 | 0.15 | 0.106 | Toll-Like receptor 2 antagonist | 0.106 0.095 CID_15055937 | CID_15055937 | |
| 0.048 | 0.124 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.054 CID_15055937 | CID_15055937 | |
| 0.049 | 0.126 | 0.078 | Adrenaline agonist | 0.078 0.06 CID_15055937 | CID_15055937 | |
| 0.066 | 0.22 | 0.141 | Amyloid beta aggregation inhibitor | 0.141 0.115 CID_15055937 | CID_15055937 | |
| 0.138 | 0.333 | 0.214 | Interleukin 2 agonist | 0.214 0.166 CID_15055937 | CID_15055937 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |